PTEN mutations were most commonly seen in chondrosarcomas (7.7%), myxoid liposarcomas (16.7%), Ewing's sarcoma and rhabdomyosarcoma (6.3%). This evidence concerns the gene PTEN and rhabdomyosarcoma.